Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Bone Neoplasms 1

Interventions

Gemcitabine 4Docetaxel 33-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2Radiotherapy 1Radiation 1Ibandronic Acid 1Grafton demineralized bone matrix gel 1Etoricoxib 1Duration of Therapy 1Drug Therapy 1Cryotherapy 1Cryosurgery 1Ascorbic Acid 1Anesthesia, Epidural 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Bone Neoplasms × Etoricoxib × Clear all
NCT00095017 2022-02-16

Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)

Organon and Co

Phase 2 Withdrawn
Sarcoma

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡